返回今日信号

TMO

NYQ
Thermo Fisher Scientific Inc.
医疗保健 Diagnostics & Research United States 官网
$513.03
+1.44% 当日
AI选股 1 条

AI选股记录

次日看跌Top3 #3 评分 70 概率 56%

这个股票来自自动 AI 选股池。以后只要 CLI 写入新的 ticker,这里会自动生成个股页面,不需要手工补页面。

2026-06-03 · 历史验证
TMO

催化剂清晰且目标价下调幅度较大,股价在消息页面显示下跌约2%;但卖压不如GOOGL和CMG强,因此列第三。

风险提示:TMO属于高质量大盘医疗工具股,基本面防御属性可能限制下跌幅度; 若生命科学板块反弹或价格收复VWAP,降级卖压可能很快被吸收
该股票的历史 AI 入选记录
2026-06-03
次日看跌Top3 #3
TMO
催化剂清晰且目标价下调幅度较大,股价在消息页面显示下跌约2%;但卖压不如GOOGL和CMG强,因此列第三。
70
查看AI历史

基本信息

市值
$190.65B
市盈率 TTM
28.17
前瞻市盈率
18.82
股息率
37.00%
52周高点
$643.99
52周低点
$401.45
Beta
0.87
日均成交量
2.30M

成交结构

基于近 60 日量价数据观察资金强弱。

截至 2026-06-26
资金流强弱 MFI
59.3
中性
Chaikin 资金流 CMF
+0.145
净流入
量能变化
1.92x
放量
空头持仓比
1.19%
极低

交易信号历史

按时间回看该股票被模型捕捉到的买点信号。

共 0 条

公司简介

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

员工数量 125,000 总部 Waltham, United States

最新资讯

外部数据 Yahoo Finance MarketWatch Stock Analysis Seeking Alpha